RE:RE:RE:RE:RE:RE:RE:How do we determine fair market cap from a licensing deal?
To those guys: I've been invested for the past 4 years actually. You may have me beat with the 10 year long investment, but I dont think I missed much in those 6 years...
Also, I obviously know the value of the immune protection tech, but you clearly don't know the value of any thing else. I knew there would be an uproar as soon as I said the immune protection was not necessary for striking deals. You see, you idiots assume you know how big pharma works, you assume they wouldn't be interested without that technology. But albeit a necessary technology for the platform, Sernova is still quite capable of establishing contracts now, prior to immune protection tech going to the clinic.
Infact a partner might even be willing to help Sernova solve the immune protection equation. Getting in before the immune protection technology also presents a nice discount to big pharma, if they wait a year or two and that tech is successful, then the company just got a whole lot more expensive.
Finally, Sernova actuallywould have data on the immune protection tech that they would have received when they first acquired the technologies. The folks who originally developed these technologies would definitely have some data to present.